MwanzoTWST • NASDAQ
add
Twist Bioscience Corp
$ 54.92
Baada ya Saa za Kazi:(0.80%)-0.44
$ 54.48
Imefungwa: 18 Feb, 20:00:00 GMT -5 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 52.88
Bei za siku
$ 52.48 - $ 57.88
Bei za mwaka
$ 23.30 - $ 57.88
Thamani ya kampuni katika soko
3.37B USD
Wastani wa hisa zilizouzwa
1.52M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 103.70M | 16.89% |
Matumizi ya uendeshaji wa biashara | 86.87M | 12.12% |
Mapato halisi | -30.51M | 3.44% |
Kiwango cha faida halisi | -29.42 | 17.38% |
Mapato kwa kila hisa | -0.50 | 5.66% |
EBITDA | -27.01M | 5.45% |
Asilimia ya kodi ya mapato | -0.84% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 197.95M | -26.91% |
Jumla ya mali | 638.08M | 4.85% |
Jumla ya dhima | 181.99M | 19.23% |
Jumla ya hisa | 456.10M | — |
hisa zilizosalia | 61.31M | — |
Uwiano wa bei na thamani | 7.11 | — |
Faida inayotokana na mali | -12.85% | — |
Faida inayotokana mtaji | -14.52% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -30.51M | 3.44% |
Pesa kutokana na shughuli | -24.81M | -15.80% |
Pesa kutokana na uwekezaji | -9.93M | -546.68% |
Pesa kutokana na ufadhili | elfu 298.00 | -98.34% |
Mabadiliko halisi ya pesa taslimu | -34.44M | -578.89% |
Mtiririko huru wa pesa | -25.86M | -130.04% |
Kuhusu
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2013
Tovuti
Wafanyakazi
979
